-
1
-
-
0030597246
-
Primary biliary cirrhosis
-
Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996;335:1570-80.
-
(1996)
N Engl J Med
, vol.335
, pp. 1570-1580
-
-
Kaplan, M.M.1
-
2
-
-
17544379813
-
Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines
-
Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology 2000;31:1005-13.
-
(2000)
Hepatology
, vol.31
, pp. 1005-1013
-
-
Heathcote, E.J.1
-
3
-
-
0025876404
-
A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis
-
UDCA-PBC Study Group
-
Poupon RE, Balkau B, Eschwege E, et al. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group. N Engl J Med 1991;324:1548-54.
-
(1991)
N Engl J Med
, vol.324
, pp. 1548-1554
-
-
Poupon, R.E.1
Balkau, B.2
Eschwege, E.3
-
4
-
-
0028331716
-
Ursodeoxycholic acid in the treatment of primary biliary cirrhosis
-
Lindor KD, Dickson ER, Baldus WP, et al. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 1994;106:1284-90.
-
(1994)
Gastroenterology
, vol.106
, pp. 1284-1290
-
-
Lindor, K.D.1
Dickson, E.R.2
Baldus, W.P.3
-
5
-
-
19144370923
-
Time course of histological progression in primary biliary cirrhosis
-
Locke GR III, Therneau TM, Ludwig J, et al. Time course of histological progression in primary biliary cirrhosis. Hepatology 1996;23:52-6.
-
(1996)
Hepatology
, vol.23
, pp. 52-56
-
-
Locke III, G.R.1
Therneau, T.M.2
Ludwig, J.3
-
6
-
-
0033658752
-
The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis
-
Corpechot C, Carrat F, Bonnand AM, et al. The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis. Hepatology 2000;32:1196-9.
-
(2000)
Hepatology
, vol.32
, pp. 1196-1199
-
-
Corpechot, C.1
Carrat, F.2
Bonnand, A.M.3
-
7
-
-
0032898075
-
Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression
-
Degott C, Zafrani ES, Callard P, et al. Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression. Hepatology 1999;29:1007-12.
-
(1999)
Hepatology
, vol.29
, pp. 1007-1012
-
-
Degott, C.1
Zafrani, E.S.2
Callard, P.3
-
8
-
-
0032979123
-
Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis
-
Angulo P, Batts KP, Therneau TM, et al. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis. Hepatology (Baltimore, Md.) 1999;29:644-7.
-
(1999)
Hepatology (Baltimore, Md.)
, vol.29
, pp. 644-647
-
-
Angulo, P.1
Batts, K.P.2
Therneau, T.M.3
-
9
-
-
0025220745
-
Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study
-
Balasubramaniam K, Grambsch PM, Wiesner RH, et al. Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study. Gastroenterology 1990;98:1567-71.
-
(1990)
Gastroenterology
, vol.98
, pp. 1567-1571
-
-
Balasubramaniam, K.1
Grambsch, P.M.2
Wiesner, R.H.3
-
10
-
-
0025300411
-
The demography of primary biliary cirrhosis in Ontario, Canada
-
Witt-Sullivan H, Heathcote J, Cauch K, et al. The demography of primary biliary cirrhosis in Ontario, Canada. Hepatology 1990;12:98-105.
-
(1990)
Hepatology
, vol.12
, pp. 98-105
-
-
Witt-Sullivan, H.1
Heathcote, J.2
Cauch, K.3
-
11
-
-
0034000476
-
Impact of fatigue on the quality of life of patients with primary biliary cirrhosis
-
Huet PM, Deslauriers J, Tran A, et al. Impact of fatigue on the quality of life of patients with primary biliary cirrhosis. Am J Gastroenterol 2000;95:760-7.
-
(2000)
Am J Gastroenterol
, vol.95
, pp. 760-767
-
-
Huet, P.M.1
Deslauriers, J.2
Tran, A.3
-
12
-
-
1642279670
-
Fatigue in chronic cholestasis
-
Milkiewicz P, Heathcote EJ. Fatigue in chronic cholestasis. Gut 2004;53:475-7.
-
(2004)
Gut
, vol.53
, pp. 475-477
-
-
Milkiewicz, P.1
Heathcote, E.J.2
-
13
-
-
0025723445
-
Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome
-
Demitrack MA, Dale JK, Straus SE, et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991;73:1224-34.
-
(1991)
J Clin Endocrinol Metab
, vol.73
, pp. 1224-1234
-
-
Demitrack, M.A.1
Dale, J.K.2
Straus, S.E.3
-
14
-
-
0028793555
-
Defective corticotropin-releasing hormone mediated neuroendocrine and behavioral responses in cholestatic rats: Implications for cholestatic liver disease-related sickness behaviors
-
Swain MG, Maric M. Defective corticotropin-releasing hormone mediated neuroendocrine and behavioral responses in cholestatic rats: Implications for cholestatic liver disease-related sickness behaviors. Hepatology 1995;22: 1560-4.
-
(1995)
Hepatology
, vol.22
, pp. 1560-1564
-
-
Swain, M.G.1
Maric, M.2
-
15
-
-
0028167781
-
Alterations in hypothalamic mu-opiate receptor-mediated responses but not methionine enkephalin or proenkephalin messenger RNA levels in rats with acute cholestasis
-
Swain MG. Alterations in hypothalamic mu-opiate receptor-mediated responses but not methionine enkephalin or proenkephalin messenger RNA levels in rats with acute cholestasis. Hepatology 1994;20:700-5.
-
(1994)
Hepatology
, vol.20
, pp. 700-705
-
-
Swain, M.G.1
-
16
-
-
0031014488
-
Is fatigue associated with cholestasis mediated by altered central neurotransmission?
-
Jones EA, Yurdaydin C. Is fatigue associated with cholestasis mediated by altered central neurotransmission? Hepatology 1997;25:492-4.
-
(1997)
Hepatology
, vol.25
, pp. 492-494
-
-
Jones, E.A.1
Yurdaydin, C.2
-
17
-
-
0344258269
-
Relief from profound fatigue associated with chronic liver disease by long-term ondansetron therapy
-
Jones EA. Relief from profound fatigue associated with chronic liver disease by long-term ondansetron therapy. Lancet 1999;354:397.
-
(1999)
Lancet
, vol.354
, pp. 397
-
-
Jones, E.A.1
-
18
-
-
12144287041
-
Fatigue and primary biliary cirrhosis: Association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels
-
Forton DM, Patel N, Prince M, et al. Fatigue and primary biliary cirrhosis: Association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels. Gut 2004;53:587-92.
-
(2004)
Gut
, vol.53
, pp. 587-592
-
-
Forton, D.M.1
Patel, N.2
Prince, M.3
-
19
-
-
0035795641
-
Grip strength and subjective fatigue in patients with primary biliary cirrhosis
-
Goldblatt J, James OF, Jones DE. Grip strength and subjective fatigue in patients with primary biliary cirrhosis. J Am Med Assoc 2001;285:2196-7.
-
(2001)
J Am Med Assoc
, vol.285
, pp. 2196-2197
-
-
Goldblatt, J.1
James, O.F.2
Jones, D.E.3
-
20
-
-
0031797111
-
Fatigue in primary biliary cirrhosis
-
Cauch-Dudek K, Abbey S, Stewart DE, et al. Fatigue in primary biliary cirrhosis. Gut 1998;43:705-10.
-
(1998)
Gut
, vol.43
, pp. 705-710
-
-
Cauch-Dudek, K.1
Abbey, S.2
Stewart, D.E.3
-
21
-
-
0036238069
-
The true impact of fatigue in primary biliary cirrhosis: A population study
-
Goldblatt J, Taylor PJ, Lipman T, et al. The true impact of fatigue in primary biliary cirrhosis: A population study. Gastroenterology 2002;122:1235-41.
-
(2002)
Gastroenterology
, vol.122
, pp. 1235-1241
-
-
Goldblatt, J.1
Taylor, P.J.2
Lipman, T.3
-
22
-
-
0033765330
-
Reliability and validity of the NIDDK-QA instrument in the assessment of quality of life in ambulatory patients with cholestatic liver disease
-
Kim WR, Lindor KD, Malinchoc M, et al. Reliability and validity of the NIDDK-QA instrument in the assessment of quality of life in ambulatory patients with cholestatic liver disease. Hepatology 2000;32:924-9.
-
(2000)
Hepatology
, vol.32
, pp. 924-929
-
-
Kim, W.R.1
Lindor, K.D.2
Malinchoc, M.3
-
23
-
-
0034014136
-
Validation of a fatigue impact score in primary biliary cirrhosis: Towards a standard for clinical and trial use
-
Prince MI, James OF, Holland NP, et al. Validation of a fatigue impact score in primary biliary cirrhosis: Towards a standard for clinical and trial use. J Hepatol 2000;32:368-73.
-
(2000)
J Hepatol
, vol.32
, pp. 368-373
-
-
Prince, M.I.1
James, O.F.2
Holland, N.P.3
-
24
-
-
0024406354
-
Prognosis in primary biliary cirrhosis: Model for decision making
-
Dickson ER, Grambsch PM, Fleming TR, et al. Prognosis in primary biliary cirrhosis: Model for decision making. Hepatology 1989;10:1-7.
-
(1989)
Hepatology
, vol.10
, pp. 1-7
-
-
Dickson, E.R.1
Grambsch, P.M.2
Fleming, T.R.3
-
25
-
-
0024433049
-
Extramural cross-validation of the Mayo primary biliary cirrhosis survival model establishes its generalizability
-
Grambsch PM, Dickson ER, Kaplan M, et al. Extramural cross-validation of the Mayo primary biliary cirrhosis survival model establishes its generalizability. Hepatology 1989;10:846-50.
-
(1989)
Hepatology
, vol.10
, pp. 846-850
-
-
Grambsch, P.M.1
Dickson, E.R.2
Kaplan, M.3
-
26
-
-
20044383403
-
Anemia is a major determinant of fatigue in patients with cirrhosis
-
Kontorinis N, Bodian C, DePalo L, et al. Anemia is a major determinant of fatigue in patients with cirrhosis (abstract). Gastroenterology 2004;126:A-730.
-
(2004)
Gastroenterology
, vol.126
-
-
Kontorinis, N.1
Bodian, C.2
DePalo, L.3
-
27
-
-
2442667784
-
Generic and disease-specific health related quality of life in non-cirrhotic, cirrhotic and transplanted liver patients: A cross-sectional study
-
van der Plas SM, Hansen BE, de Boer JB, et al. Generic and disease-specific health related quality of life in non-cirrhotic, cirrhotic and transplanted liver patients: A cross-sectional study. BMC Gastroenterol 2003;3:33.
-
(2003)
BMC Gastroenterol
, vol.3
, pp. 33
-
-
Van Der Plas, S.M.1
Hansen, B.E.2
De Boer, J.B.3
-
28
-
-
0036904162
-
Fatigue in patients with chronic hepatitis C
-
Poynard T, Cacoub P, Ratziu V, et al. Fatigue in patients with chronic hepatitis C. J Viral Hepat 2002;9:295-303.
-
(2002)
J Viral Hepat
, vol.9
, pp. 295-303
-
-
Poynard, T.1
Cacoub, P.2
Ratziu, V.3
|